Quantitative Pre-clinical Fluorescence Imaging of Cancer Metastasis

Quantitative pre-clinical fluorescence imaging transcends the boundaries of traditional optical imaging of biological structures and physiology by providing information at the molecular level about disease states and therapeutic response. Traditional mouse models of cancer rely primarily on ex vivo measurements of disease morphology and histologic analysis for the assessment of tumor burden. These measurements of disease may be distant from the actual biological targets of interest and can be time consuming, expensive, and impractical for measuring local disease biology in context. Download this application note to learn about an alternative: quantitative pre-clinical fluorescence imaging of cancer metastasis.